Battipaglia, C., Vescovi, V., Foschi, M., Righi, B., Sponzilli, A., Setti, V., … Genazzani, A. D. (2025). Combined myo-inositol and Banaba (1% Corosolic Acid) improve HOMA-IR and hepatic insulin extraction index in overweight and obese postmenopausal women. Gynecological Endocrinology, 41(1). https://doi.org/10.1080/09513590.2025.2596417
Genazzani, A. D., Battipaglia, C., Foschi, M., Semprini, E., Aio, C., Spelta, E., … Meczekalski, B. (2025). Improved insulin sensitivity and reproductive profile in overweight/obese PCOS patients undergoing integrative treatment with carnitines, L-arginine, L-cysteine and myo-inositol. Gynecological Endocrinology, 41(1). https://doi.org/10.1080/09513590.2025.2458710
Genazzani, A. D., Battipaglia, C., Rusce, L., Prampolini, G., Aio, C., Ricciardiello, F., … Petrillo, T. (2024). Alpha lipoic acid administration improved both peripheral sensitivity to insulin and liver clearance of insulin reducing potential risk of diabetes and nonalcoholic fatty liver disease in overweight/obese PCOS patients. Gynecological Endocrinology, 40(1). https://doi.org/10.1080/09513590.2024.2341701
Genazzani, A. D., Battipaglia, C., Petrillo, T., Piacquadio, N., Ambrosetti, F., Arnesano, M., … Simoncini, T. (2022). Familial diabetes predisposes PCOS patients to insulin resistance (IR), reproductive impairment and hepatic dysfunction: effects of d-chiro inositol (DCI) and alpha lipoic acid (ALA) administration on hepatic insulin extraction (HIE) index. Gynecological Endocrinology, 38(8), 681–688. https://doi.org/10.1080/09513590.2022.2089107
Genazzani, A. D., Prati, A., Marchini, F., Petrillo, T., Napolitano, A., & Simoncini, T. (2019). Differential insulin response to oral glucose tolerance test (OGTT) in overweight/obese polycystic ovary syndrome patients undergoing to myo-inositol (MYO), alpha lipoic acid (ALA), or combination of both. Gynecological Endocrinology, 35(12), 1088–1093. https://doi.org/10.1080/09513590.2019.1640200
Szeliga, A., Czyzyk, A., Podfigurna, A., Genazzani, A. R., Genazzani, A. D., & Meczekalski, B. (2018). The role of kisspeptin/neurokinin B/dynorphin neurons in pathomechanism of vasomotor symptoms in postmenopausal women: from physiology to potential therapeutic applications. Gynecological Endocrinology, 34(11), 913–919. https://doi.org/10.1080/09513590.2018.1480711
Katulski, K., Podfigurna, A., Czyzyk, A. et al. Kisspeptin and LH pulsatile temporal coupling in PCOS patients. Endocrine 61, 149–157 (2018). https://doi.org/10.1007/s12020-018-1609-1
Genazzani, A. D., Prati, A., Santagni, S., Ricchieri, F., Chierchia, E., Rattighieri, E., … Artini, P. G. (2012). Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients. Gynecological Endocrinology, 28(12), 969–973. https://doi.org/10.3109/09513590.2012.685205
Genazzani, A. D., Lanzoni, C., Ricchieri, F., & Jasonni, V. M. (2008). Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome. GynecologicalEndocrinology, 24(3), 139–144. https://doi.org/10.1080/09513590801893232
Genazzani AD, Battaglia C, Malavasi B, Strucchi C, Tortolani F, Gamba O. Metformin administration modulates and restores luteinizing hormone spontaneous episodic secretion and ovarian function in nonobese patients with polycystic ovary syndrome. Fertil Steril. 2004 Jan;81(1):114-9. doi: 10.1016/j.fertnstert.2003.05.020. PMID: 14711553.
Genazzani AD, Stomati M, Bernardi F, Pieri M, Rovati L, Genazzani AR. Long-term low-dose dehydroepiandrosterone oral supplementation in early and late postmenopausal women modulates endocrine parameters and synthesis of neuroactive steroids. Fertil Steril. 2003 Dec;80(6):1495-501. doi: 10.1016/j.fertnstert.2003.06.005. PMID: 14667889.